Natera Inc Aktie
269,60 €
Deine Einschätzung
Was spricht für und gegen Natera Inc in den nächsten Jahren?
Pro
Kontra
Rendite von Natera Inc im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Natera Inc | -0,40 % | 16,96 % | 12,43 % | 96,79 % | 36,85 % | 423,50 % | 215,32 % |
| Orthofix Medical Inc. | 1,16 % | 0,57 % | -11,62 % | -24,57 % | -32,17 % | -50,84 % | -73,48 % |
| Lantheus Holdings Inc | 0,34 % | -0,11 % | -5,40 % | 90,43 % | 53,15 % | 39,05 % | - |
| IRadimed Corp | -0,66 % | -6,79 % | -12,21 % | 24,79 % | -9,04 % | - | - |
Kommentare
News
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs
Solomon Moshkevich, president of clinical diagnostics at Natera, Inc. (NASDAQ:NTRA), sold 3,410 shares of common stock on August 3, according to an SEC Form 4 filing.
Transaction value based on SEC
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests
Executive Chairman Matthew Rabinowitz reported a sale of 2,000 shares of Natera, Inc. (NASDAQ:NTRA) in a recent SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know
Matthew Rabinowitz, the executive chairman of Natera, Inc. (NASDAQ:NTRA), sold 731 shares of common stock at $267.99 per share on August 3, according to an SEC Form 4 filing.
Transaction value based





